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Objectives: The aim of this study was to compare the pattern of secretion and the expression of mucin glycoprotein-2 (MG2) and lactoferrin in individuals with or without 
periodontitis. Material and Methods: Five individuals with aggressive periodontitis (APG), 5 
with generalized chronic periodontitis (CPG) and 5 without periodontitis (CG) were enrolled 
after informed consent. Non-stimulated and stimulated submandibular and sublingual saliva 
	
				
	
	
	
		



	

	
	
	!!	
	
blot analysis revealed that stimulation led to: an increase in MG2 expression in all groups, 
and to lactoferrin expression in APG and CPG. In non-stimulated saliva, CG exhibited the 
highest expression of both glycoproteins. In stimulated saliva, CG exhibited the highest 
expression of MG2, whereas APG the highest of lactoferrin. Conclusions: The pattern of 
secretion of MG2 and lactoferrin in health and disease is complex. Although the present 
study analyzed samples from a limited number of participants, the reduced expression 
of MG2 and lactoferrin in APG and CPG under non-stimulated condition, the predominant 
circumstance of salivary secretion during the day, suggests that these salivary constituents 
may play a role in the etiopathogenesis of these diseases.
Key words: Submandibular gland. Sublingual gland. Saliva. Innate immunity. Periodontitis. 
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INTRODUCTION
Periodontal diseases (PD) are chronic 
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and nondestructive diseases of the periodontal 
supporting tissues of the teeth. Aggressive 
periodontitis is characterized by severe and rapid 
loss of periodontal attachment often commencing 
at or after puberty. Chronic periodontitis is a 
common disease that is prevalent among adults 
and seniors5,12. Even though the diagnosis and 
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parameters, new auxiliary diagnostic tools based on 
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have been studied and developed6. In particular, 
saliva has been extensively studied in relation to 
PD since it can be easily collected and analyzed22.
Saliva is necessary for the maintenance of 
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are derived in large part from the proteins that 
are present. In the oral cavity, salivary proteins 
participate in formation of the acquired enamel 
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initiate digestion, promote agglutination and 
clearance of bacteria, and protect oral tissues 
against noxious compounds produced by various 
microorganisms30.
In particular, mucin glycoprotein-2 (MG2) 
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was reported to be present in pellicle formed 
on cementum surfaces11, to exhibit candidacidal 
activity24, and to kill the periodontal pathogen 
Aggregatibacter actinomycetemcomitans26. Salivary 
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availability of this metal to microbes27. In addition, 
lactoferrin exhibits antibacterial, antimycotic, 
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35. Thus, 
MG2 and lactoferrin are active components of the 
innate immune system in the oral environment.
 Several studies reported that the levels of 
distinct salivary proteins are altered in individuals 
with PD10,14-19,32. Therefore, the present study 
was undertaken to investigate and compare the 
pattern of secretion and the expression of MG2 
and lactoferrin in individuals with aggressive 
periodontitis, chronic periodontitis and without 
periodontitis.
MATERIAL AND METHODS
Participant selection
During a 12-month period, individuals that were 
referred to the authors’ department for treatment 
and volunteered to participate in this study were 
screened. Exclusion criteria for the study included: 
pregnancy; use of antibiotics within the past 3 
months; individuals with systemic debilitating 
diseases or conditions that could affect periodontal 
status (e.g. diabetes); smokers and former 
smokers; recent trauma. Additionally, individuals 
that had aggressive or chronic periodontitis and 
had received periodontal treatment within the 
previous year were excluded in order to observe 
the expression of the salivary glycoproteins MG2 
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periodontitis.
Individuals meeting inclusion criteria received 
a complete periodontal exam that included 
assessment of probing depth, probing attachment 
level and recession, evaluation of bleeding and/or 
suppuration on probing, radiographic examination 
and complete anamnesis. Probing depths were 
measured at six sites per tooth (mesio-, mid-, 
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inclusion criteria used to differentiate the 3 groups 
were based on previous publications2-5 including:
Aggressive periodontitis group (APG): (I) 
localized aggressive periodontitis - periodontal 
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and incisors; generalized aggressive periodontitis: 
(II) generalized interproximal attachment loss 
affecting at least 3 permanent teeth other than the 
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mm. Generalized chronic periodontitis group (CPG): 
(I) more than 30% of sites involved; moderate: CAL 
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all sites with probing depths <4 mm.
Each group had 5 individuals (2 males and 
3 females) with age ranges of 19-28 years for 
APG, 36-50 years for CPG, 21-50 years for CG 
and as expected33 individuals from APG exhibited 
a lower age range. This study was independently 
reviewed and approved by the local Research Ethics 
Committee, informed consent was obtained from all 
individuals prior to their participation and subjects’ 
rights were protected at all times.
Saliva collection
Non-stimulated and stimulated submandibular 
and sublingual saliva (SMSL) was collected from 
subjects between 10:00 a.m. and 11:00 a.m. 
Subjects were asked to refrain from eating or 
drinking two h prior to collection. Subjects rinsed 
with water, and SMSL samples were collected with 
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discarded in order to avoid possible interference 
of the device dead volume. Four consecutive 
two-minute samples collected in separate 1.5 mL 
centrifuge tubes and subsequently four consecutive 
two-minute samples of stimulated SMSL were 
collected in separate 15 mL Falcon screw cap tubes. 
Gustatory stimulation of stimulated samples was 
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the tongue. Tubes of non-stimulated SMSL were 
labeled T1, T2, T3 and T4. Tubes of stimulated 
SMSL were labeled T5, T6, T7 and T8. All samples 
were kept on ice during the collection procedure, 
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samples were frozen at -20°C until used.
Gel electrophoresis
SMSL samples were thawed, and for each 
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and stimulated SMSL were lyophilized, taken up in 
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subjected to sodium dodecylsulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) on 7.5% gels.
Western blots
Proteins in gels were electrophoretically 
transferred to nitrocellulose membranes (Protran, 
Schleicher and Schuell, Keene, NH, USA) in 25 
mM Tris-HCl, pH 8.3, containing 192 mM glycine 
and 20% methanol at 100 volts for 1 h at room 
temperature. Blots were probed with rabbit 
polyclonal antibodies directed against MG2 or 
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mM Tris-HCl, pH 8.0 containing 150 mM NaCl and 
0.1% Tween-20 (TBST) for 5 min and blocked with 
5% non-fat, dried milk in TBST overnight at room 
temperature. After blocking, blots were washed 
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the anti-MG2 antibody has been demonstrated in 
previous studies25,29, and this antibody was diluted 
1:1000. The anti-lactoferrin antibody (Sigma, St. 
Louis, MO, USA) was diluted 1:2,000. Antibodies 
were diluted in 1% milk/TBST and incubated for 1 
h at room temperature. After washing, blots were 
incubated with the second antibody, which was 
anti-rabbit IgG coupled to alkaline phosphatase 
(Promega, Madison, WI, USA) diluted 1:7,500 in 
1% milk/TBST for 1 h at room temperature. Blots 
were washed three times in TBST for 5 min and 
color development was carried out with 5-bromo-
4-chloro-3-indolyl-phosphate (BCIP) and nitro blue 
tetrazolium (NBT) according to the manufacturer’s 
(Promega) instructions.
Statistical analysis
Comparison of the effect of non-stimulated and 
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repeated-measures analysis of variance (ANOVA; 
post hoc analysis – Fisher’s exact test). The 
statistical analysis was performed using StatView 
4.5 (Abacus Concepts Inc., Berkeley, CA, USA).
RESULTS
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obtained at rest (T1–T4) were lower than stimulated 
(T5–T8) conditions in all groups. The mean value 
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0.46±0.18 mL/min for APG, 0.30±0.20 for CPG and 
0.47±0.31 for CG. Under stimulated conditions, 
it was 1.79±0.92 ml/min for APG, 1.47±0.38 
mL/min for CPG and 1.87±0.99 mL/min for CG. 
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in all groups (APG - p=0.01; CPG - p=0.03; CG - 
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for non-stimulated or stimulated conditions, and 
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not differ among groups.
 
Analysis of the secretion patterns
MG2 immunoreactive bands from APG, CPG and 
CG exhibited a weak immunoreactive signal under 
non-stimulated conditions whereas upon gustatory 
stimulation, the intensity of the immunoreactive 
signal increased (Figure 1A). Blots probed with 
anti-lactoferrin antibodies revealed a difference 
in banding pattern among groups (Figure 1B); 
individuals from APG and CPG had an increase in 
expression upon gustatory stimulation, whereas 
individuals from CG exhibited a decrease.
Comparison of glycoprotein expression
Comparison of expression among groups 
under non-stimulated conditions revealed that 
CG exhibited the highest expression of MG2 and 
lactoferrin (Figures 2A and 2B). APG showed the 
lowest levels of MG2, and CPG of lactoferrin (Figures 
2A and 2B). Comparison of expression among 
groups under stimulated conditions showed that CG 
exhibited the highest expression of MG2, whereas 
APG the highest of lactoferrin (Figures 2C and 2D). 
Again, APG showed the lowest levels of MG2, and 
Figure 1- Pattern of secretion of salivary glycoproteins. A 
- Representative Western blots of MG2 pattern observed 
in all individuals from each group. B - Representative 
Western blots of lactoferrin pattern observed in all 
individuals from each group. T1–T4 (non-stimulated 
submandibular and sublingual saliva-SMSL) and T5–T8 
(stimulated submandibular and sublingual saliva-SMSL). 
APG-Aggressive periodontitis group; CPG-Generalized 
chronic periodontitis group; CG-Control group
Figure 2- Comparison of glycoproteins expression under 
non-stimulated (A, B) or stimulated (C, D) conditions. 
A-MG2 Western blot; B-Lactoferrin Western blot; 
C-MG2 Western blot; D-Lactoferrin Western blot; APG-
Aggressive periodontitis group; CPG-Generalized chronic 
periodontitis group; CG-Control group
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CPG of lactoferrin (Figures 2C and 2D).
DISCUSSION
The infectious nature of the periodontitis is 
	
	 
 	 
  	  
 
	
	&	

	9,28,34. 
Additionally, initiation and progression of periodontal 
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conditions (risk factors), such as diabetes mellitus 
and cigarette smoking, as well as potentially 
important risk indicators including stress13. Salivary 
proteins are not included in the category of risk 
indicators, but this concept is being explored.
Investigation of salivary proteins in individuals 
with periodontitis may be useful to enhance the 
knowledge of their role in this population. Statistical 
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groups, stimulated or non-stimulated. Therefore, 
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SMSL by immunoblotting, instead of equal amounts 
of protein. 
It has been previously reported that MG2 
can agglutinate several pathogens from the oral 
cavity8,23,31, and in addition, interact and kill the 
periodontal pathogen A. actinomycetemcomitans26. 
In a previous study, the concentration of MG2 
was determined in stimulated whole saliva of 
subjects suffering from A. actinomycetemcomitans 
associated PD14. It has been reported that MG2 
output in the diseased subjects was decreased 
at least by a factor three in comparison to 
periodontally healthy subjects and that this low 
concentration of MG2 suggested a decline in mucin 
defense and consequently, a higher susceptibility 
to oral infections.
In the present study, blotting analysis revealed 
that all groups showed an increase of MG2 
expression upon stimulation revealing a similar 
pattern (Figures 1A and 1B). A previous study that 
analyzed the pattern of secretion of MG2 in samples 
from individuals without periodontitis7 reported 
that PAS stained gels did not reveal differences in 
MG2 secretion patterns upon stimulation. However, 
Western blots indicated that MG2 expression was 
enhanced after stimulation; a result that is in 
agreement with the observed pattern in the present 
study for CG.
It was also observed that individuals without 
periodontitis exhibited the highest expression of 
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(Figures 2A and 2C). The reduced output of this 
salivary mucin in individuals with aggressive 
periodontitis observed on blots (Figures 2A and 2C) 
is similar to the one described14. Since in chronic 
periodontitis the destruction of the periodontal 
ligament and loss of the adjacent supporting 
bone usually displays a slow to moderate rate of 
progression, we hypothesize that the intermediate 
expression of MG2 observed in individuals belonging 
to this group (Figures 2A and 2C) could in part 
contribute to decrease the disease progression rate 
in comparison to aggressive periodontitis.
Salivary lactoferrin is a single chain iron-
binding glycoprotein that binds ferric ions and 
possesses antibacterial, antimycotic, antiviral and 
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	35. It also exhibits the 
ability to penetrate bacterial cell membranes36. 
The impact of a surgical periodontal treatment 
in the concentration of this glycoprotein in non-
stimulated and stimulated whole saliva samples 
from individuals with chronic periodontitis was 
analyzed previously21. It was reported that the 
concentrations decreased significantly in both 
non-stimulated and stimulated samples after the 
surgical treatment, suggesting that lactoferrin may 
be suitable for monitoring periodontal treatment 
results.
Another study evaluated lactoferrin levels from 
individuals with localized aggressive periodontitis 
before and after periodontal therapy. Among 
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was obtained from these individuals and from 
periodontally healthy controls. Differences between 
groups and with respect to periodontal therapy 
were not observed in lactoferrin concentrations in 
whole saliva32.
Concentrations and output of lactoferrin were 
also determined in whole saliva samples from 
subjects suffering from A. actinomycetemcomitans-
associated PD14. The output of lactoferrin was 
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subjects although a higher iron-saturation of 
lactoferrin in subjects with the disease was 
described.
Lactoferrin expression was examined in whole 
and parotid saliva from individuals with localized 
aggressive periodontitis and compared to age-
, gender-, and race-matched controls10. It was 
reported that whole saliva from the test group 
had higher levels of the glycoprotein although the 
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suggesting that lactoferrin from individuals with 
localized aggressive periodontitis might interfere 
in the disease progression.
In the present study, it was observed that 
individuals with or without periodontitis exhibited 
a similar pattern of lactoferrin secretion (Figure 
1B). Comparison of expression among groups 
revealed that under non-stimulated conditions 
individuals without periodontitis (CG) showed 
the highest expression of lactoferrin (Figure 2B) 
whereas under stimulated conditions individuals 
with periodontitis (APG and CPG) exhibited a more 
intense immunoreactive signal (Figure 2D).
The higher expression of this glycoprotein 
Differential expression of salivary glycoproteins in aggressive and chronic periodontitis
2012;20(2):180-5
J Appl Oral Sci. 184
in individuals with aggressive periodontitis is 
in agreement with a previous report10, but is in 
contrast to others14,32. The differences in these 
two studies from the present could be at least in 
part explained by variations in samples that were 
analyzed (i.e. SMSL versus whole saliva) since 
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will be present in samples from whole saliva.
The increase in the amount of lactoferrin in 
stimulated samples from SMSL of individuals with 
generalized chronic periodontitis (Figure 2D) found 
in the present study is in contrast to another report21 
in which the levels of lactoferrin in samples from 
non-stimulated whole saliva were higher than in 
samples of stimulated whole saliva. Again, the 
differences in this study from the present could also 
be in part explained by SMSL versus whole saliva.
Exclusion of individuals that had aggressive 
or chronic periodontitis and received periodontal 
treatment during the last year had a direct 
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the expression of salivary proteins among individuals 
with aggressive and chronic periodontitis at the 
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stimulation over time in the expression of MG2 
and lactoferrin in individuals with periodontitis. 
Analysis of these salivary constituents appears to 
have potential to be used as markers for aggressive 
or chronic periodontitis, and since both MG2 and 
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domains could be considered as possible candidates 
for the development of new drugs that in principle 
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The biological plausibility of the differences 
observed in SMSL physiology in our study could 
be derived by periodontal bacterial components 
triggering the host-immune response, and causing 
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mediators. It has been described that these 
molecules traveling via blood to other organs and 
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It is important to mention that the observed 
results show that future studies should purposely 
collect non-stimulated and/or stimulated saliva 
samples since protein expression under these 
circumstances varies. The reduced expression 
of these glycoproteins observed in APG and CPG 
particularly under non-stimulated conditions, 
decrease the oral cavity innate defense mechanisms 
provided by these salivary components in these 
individuals.
CONCLUSIONS
It remains unclear to what extent the reduced 
output of MG2 and lactoferrin might impact 
the etiopathogenesis of aggressive and chronic 
periodontitis. However, the data suggest an active 
role of these glycoproteins in the innate immune 
regulation of periodontal bacterial colonization and 
disease progression.
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